DNAprint Genomics (DNAG)

[trebeg]

onco...first of all, any talk of a RS is pure conjecture and is the type of nonsense posted by bashers as a scare tactic. The company has not sad or even indicated that a RS is an option at this time or any time in the future. Only posters on message boards bring it up. To answer your question, historically, RS's are bad for investors period. Very seldom does the investor ever benefit. The PPS almost always goes back to pre-RS levels if not lower. Occasionally, there may be a slight gain immediatetly following the RS before the decent begins. If you want to make money with DNAG, then I would buy as many shares NOW as you can feel comfortable doing. It could tank, but IMO think now is the time to buy and hold. This is a LONG TERM scenario. Don't listen to the traders/bashers. Too much potential here and IMO patience will be heavily rewarded. GLTY!